Author: Maslow, Joel
Title: GeneOne Life Science Document date: 2018_10_26
ID: w7hf3kji_27
Snippet: GeneOne considers carefully in-house need for expertise versus cost. The key consideration is the ability to maintain quality and safety in drug development. Internal growth has been carefully monitored and conservative to ensure long-term viability and success......
Document: GeneOne considers carefully in-house need for expertise versus cost. The key consideration is the ability to maintain quality and safety in drug development. Internal growth has been carefully monitored and conservative to ensure long-term viability and success.
Search related documents:
Co phrase search for related documents- carefully consider and long term: 1, 2, 3, 4, 5
- carefully monitor and long term: 1, 2, 3, 4, 5, 6, 7
- drug development and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
- drug development and safety quality: 1, 2, 3, 4, 5, 6, 7, 8
- internal growth and long term: 1
- key consideration and long term: 1, 2, 3, 4
- long term and safety quality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
Co phrase search for related documents, hyperlinks ordered by date